1-20 of 23
Frank L. Meyskens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

Available to Purchase
Jason A. Zell, Christine E. McLaren, Timothy R. Morgan, Michael J. Lawson, Sherif Rezk, C. Gregory Albers, Wen-Pin Chen, Joseph C. Carmichael, Jinah Chung, Ellen Richmond, L.M. Rodriguez, Eva Szabo, Leslie G. Ford, Michael N. Pollak, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (2): 203–212.
https://doi.org/10.1158/1940-6207.CAPR-18-0262
Published: 05 February 2020
View articletitled, A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index
Open the PDF for A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index in another window
Includes: Supplementary data
Journal Articles

Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis

Free
Kevin M. Huang, Sherry Liang, Steven Yeung, Etuajie Oiyemhonlan, Kristan H. Cleveland, Cyrus Parsa, Robert Orlando, Frank L. Meyskens, Jr, Bradley T. Andresen, Ying Huang
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2017) 10 (10): 598–606.
https://doi.org/10.1158/1940-6207.CAPR-17-0132
Published: 01 October 2017
View articletitled, Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis
Open the PDF for Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis in another window
Includes: Supplementary data
Journal Articles

Deciphering the Effect of Metformin on Prostate Cancer Risk by Ethnicity

Free
Edward Uchio, Frank L. Meyskens, Ping H. Wang
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2016) 9 (10): 777–778.
https://doi.org/10.1158/1940-6207.CAPR-16-0173
Published: 04 October 2016
View articletitled, Deciphering the Effect of Metformin on Prostate Cancer Risk by Ethnicity
Open the PDF for Deciphering the Effect of Metformin on Prostate Cancer Risk by Ethnicity in another window
Journal Articles

Risk Factor Models and Personalized Health: Opportunities and Challenges for Asymptomatic Individuals

Free
Frank L. Meyskens, Jr
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2016) 9 (1): 11–12.
https://doi.org/10.1158/1940-6207.CAPR-15-0401
Published: 06 January 2016
View articletitled, Risk Factor Models and Personalized Health: Opportunities and Challenges for Asymptomatic Individuals
Open the PDF for Risk Factor Models and Personalized Health: Opportunities and Challenges for Asymptomatic Individuals in another window
Journal Articles

Abstract A21: A Phase IIa trial of metformin for colorectal cancer risk reduction among patients with a history of colorectal adenomas and elevated body mass index

Free
Jason A. Zell, Christine E. McLaren, Timothy R. Morgan, Michael J. Lawson, Sherif Rezk, Gregory C. Albers, Wen-Pin Chen, Joseph C. Carmichael, Luz Rodriguez, Eva Szabo, Leslie Ford, Michael Pollak, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (10_Supplement): A21.
https://doi.org/10.1158/1940-6215.PREV-14-A21
Published: 02 October 2015
View articletitled, Abstract A21: A Phase IIa trial of metformin for colorectal cancer risk reduction among patients with a history of colorectal adenomas and elevated body mass index
Journal Articles

A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP

Free
Timothy R. Morgan, Kathryn Osann, Teodoro Bottiglieri, Neville Pimstone, John C. Hoefs, Ke-Qin Hu, Tarek Hassanein, Thomas D. Boyer, Lorene Kong, Wen-Pin Chen, Ellen Richmond, Rachel Gonzalez, Luz M. Rodriguez, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (9): 864–872.
https://doi.org/10.1158/1940-6207.CAPR-15-0029
Published: 01 September 2015
View articletitled, A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP
Open the PDF for A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP in another window
Includes: Supplementary data
Journal Articles

A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum

Free
Daniel L. Gillen, Frank L. Meyskens, Timothy R. Morgan, Jason A. Zell, Robert Carroll, Richard Benya, Wen-Pin Chen, Allen Mo, Chris Tucker, Asmita Bhattacharya, Zhiliang Huang, Myra Arcilla, Vanessa Wong, Jinah Chung, Rachel Gonzalez, Luz Maria Rodriguez, Eva Szabo, Daniel W. Rosenberg, Steven M. Lipkin
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (3): 222–230.
https://doi.org/10.1158/1940-6207.CAPR-14-0148
Published: 05 March 2015
View articletitled, A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum
Open the PDF for A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum in another window
Includes: Supplementary data
Journal Articles

Abstract CN02-05: Phase IIb randomized clinical chemoprevention trial of a soybean-derived compound (Bowman-Birk inhibitor concentrate) for oral leukoplakia

Free
Frank L. Meyskens, Jr., Thomas Taylor, William Armstrong, Lorene Kong, Mai Gu, Rachel Gonzalez, Michael Villa, Vanessa Wong, Angela Garcia, Marjorie Perloff, Ann Kennedy, Steven Wan, Jeffrey H. Ware, Diana Messadi, Jachen Lorch, Lori Wirth, Zachery Jaffe, W. Jarrad Goodwin, Francisco Civantos, Maureen Sullivan, Mary Reid, Mehai Merciznu, Vijayvel Jayaprakash, Alexander Ross Kerr, Anh Le
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): CN02-05.
https://doi.org/10.1158/1940-6207.PREV-10-CN02-05
Published: 24 October 2014
View articletitled, Abstract CN02-05: Phase IIb randomized clinical chemoprevention trial of a soybean-derived compound (Bowman-Birk inhibitor concentrate) for oral leukoplakia
Journal Articles

Abstract A9: UDP-glucuronosyltransferase 2B7 (UGT2B7) inhibits melanoma invasiveness

Free
Ryan W. Dellinger, Harry H. Matundan, Alisa L. West, Frank L. Meyskens, Jr.
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): A9.
https://doi.org/10.1158/1940-6207.PREV-10-A9
Published: 24 October 2014
View articletitled, Abstract A9: UDP-glucuronosyltransferase 2B7 (UGT2B7) inhibits melanoma invasiveness
Journal Articles

Abstract B82: Two factors contribute to negative results of a phase-IIB chemoprevention trial of Bowman-Birk inhibitor concentrate on oral leukoplakia

Free
Thomas H. Taylor, Ann R. Kennedy, Marjorie Perloff, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): B82.
https://doi.org/10.1158/1940-6207.PREV-11-B82
Published: 23 October 2014
View articletitled, Abstract B82: Two factors contribute to negative results of a phase-IIB chemoprevention trial of Bowman-Birk inhibitor concentrate on oral leukoplakia
Journal Articles

Abstract PR-01: Properties of adenomas in subjects treated with difluoromethylornithine and sulindac for reduction of colorectal adenomas

Free
Philip M. Carpenter, Wen-Pin Chen, Christine E. McLaren, Eugene W. Gerner, Frank L. Meyskens, Jr.
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): PR-01.
https://doi.org/10.1158/1940-6207.PREV-11-PR-01
Published: 23 October 2014
View articletitled, Abstract PR-01: Properties of adenomas in subjects treated with difluoromethylornithine and sulindac for reduction of colorectal adenomas
Journal Articles

Abstract A29: Rectal mucosal polyamine and PGE2 levels and risk of colorectal adenomas in a phase IIb/III trial of combination difluoromethylornithine (DFMO) plus sulindac

Free
Patricia A. Thompson, Betsy C. Wertheim, Jason A. Zell, Bonnie LeFleur, Wen‐Pin Chen, Christine E. McLaren, Frank L. Meyskens, Eugene W. Gerner
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (1_Supplement): A29.
https://doi.org/10.1158/1940-6207.PREV-09-A29
Published: 21 October 2014
View articletitled, Abstract A29: Rectal mucosal polyamine and PGE2 levels and risk of colorectal adenomas in a phase IIb/III trial of combination difluoromethylornithine (DFMO) plus sulindac
Journal Articles

Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Free
Demetrius Albanes, Cathee Till, Eric A. Klein, Phyllis J. Goodman, Alison M. Mondul, Stephanie J. Weinstein, Philip R. Taylor, Howard L. Parnes, J. Michael Gaziano, Xiaoling Song, Neil E. Fleshner, Powel H. Brown, Frank L. Meyskens, Jr, Ian M. Thompson
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2014) 7 (9): 886–895.
https://doi.org/10.1158/1940-6207.CAPR-14-0058
Published: 01 September 2014
View articletitled, Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Open the PDF for Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) in another window
Includes: Supplementary data
Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology

Free
Kenneth G. Linden, Sancy A. Leachman, Jonathan S. Zager, James G. Jakowatz, Jaye L. Viner, Christine E. McLaren, Ronald J. Barr, Philip M. Carpenter, Wen-Pin Chen, Craig A. Elmets, Joseph A. Tangrea, Sung-Jig Lim, Alistair J. Cochran, Frank L. Meyskens, Jr
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2014) 7 (5): 496–504.
https://doi.org/10.1158/1940-6207.CAPR-13-0189
Published: 01 May 2014
View articletitled, A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology
Open the PDF for A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology in another window
Includes: Supplementary data
Journal Articles

Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial

Free
William B. Armstrong, Thomas H. Taylor, Ann R. Kennedy, Raymond J. Melrose, Diana V. Messadi, Mai Gu, Anh D. Le, Marjorie Perloff, Francisco Civantos, William Jarrard Goodwin, Lori J. Wirth, Alexander Ross Kerr, Frank L. Meyskens, Jr
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2013) 6 (5): 410–418.
https://doi.org/10.1158/1940-6207.CAPR-13-0004
Published: 01 May 2013
View articletitled, Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial
Open the PDF for Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial in another window
Includes: Supplementary data
Journal Articles

Back to the Future: Mechanism-Based, Mutation-Specific Combination Chemoprevention with a Synthetic Lethality Approach

Free
Frank L. Meyskens, Jr, Eugene W. Gerner
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (5): 628–632.
https://doi.org/10.1158/1940-6207.CAPR-11-0162
Published: 03 May 2011
View articletitled, Back to the Future: Mechanism-Based, Mutation-Specific Combination Chemoprevention with a Synthetic Lethality Approach
Open the PDF for Back to the Future: Mechanism-Based, Mutation-Specific Combination Chemoprevention with a Synthetic Lethality Approach in another window
Includes: Supplementary data
Journal Articles

Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic

Free
Frank L. Meyskens, Jr., Gregory A. Curt, Dean E. Brenner, Gary Gordon, Ronald B. Herberman, Olivera Finn, Gary J. Kelloff, Samir N. Khleif, Caroline C. Sigman, Eva Szabo
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (3): 311–323.
https://doi.org/10.1158/1940-6207.CAPR-09-0014
Published: 02 March 2011
View articletitled, Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic
Open the PDF for Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic in another window
Includes: Supplementary data
Journal Articles

Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia

Free
Robert E. Carroll, Richard V. Benya, Danielle Kim Turgeon, Shaiju Vareed, Malloree Neuman, Luz Rodriguez, Madhuri Kakarala, Philip M. Carpenter, Christine McLaren, Frank L. Meyskens, Jr, Dean E. Brenner
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (3): 354–364.
https://doi.org/10.1158/1940-6207.CAPR-10-0098
Published: 02 March 2011
View articletitled, Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Open the PDF for Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia in another window
Includes: Supplementary data
Journal Articles

The Effectiveness of Chemoprevention Agents Is Underestimated When Lesion Sizes Are Rounded

Free
Thomas H. Taylor, William B. Armstrong, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (2): 136–139.
https://doi.org/10.1158/1940-6207.CAPR-09-0114
Published: 03 February 2010
View articletitled, The Effectiveness of Chemoprevention Agents Is Underestimated When Lesion Sizes Are Rounded
Open the PDF for The Effectiveness of Chemoprevention Agents Is Underestimated When Lesion Sizes Are Rounded in another window
Includes: Supplementary data
Journal Articles

Food Extracts for Chemoprevention: Quo Vadis?

Free
Frank L. Meyskens, Jr.
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2009) 2 (7): 608–610.
https://doi.org/10.1158/1940-6207.CAPR-09-0102
Published: 07 July 2009
View articletitled, Food Extracts for Chemoprevention: Quo Vadis?
Open the PDF for Food Extracts for Chemoprevention: Quo Vadis? in another window
Includes: Supplementary data